Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05903885 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment closed, study ongoing Eligibility criteria expanded, about 9 words · Site details revised at 2 of 2 sites · Publications: details revised at 25 of 29 entries Show 3 more changesShow less
    • Eligibility criteria expanded, about 9 words
    • Site details revised at 2 of 2 sites
    • Publications: details revised at 25 of 29 entries
  2. Primary completion date: Oct 1, 2025 to Jun 1, 2026 Completion date: Jan 2026 to Oct 2026v11 Show 1 more changeShow less
    • Completion date: Jan 2026 to Oct 2026
  3. Primary completion date: Jun 2025 to Oct 1, 2025v10
  4. Primary endpoint revised Primary completion date: Mar 2025 to Jun 2025 · Interventions: On-site Fecal Immunochemical Test (FIT) Kit Distribution (Other), Onsite with social media advertising Fecal Immunochemical Test (FIT) Kit… to On-site Fecal Immunochemical Test (FIT) Kit Distribution (Other), On-site With Social Media Advertising Fecal Immunochemical Test (FIT) Kit… · Eligibility criteria shortened, about 11 words · 3 morev9 Show 6 more changesShow less
    • Primary completion date: Mar 2025 to Jun 2025
    • Interventions: On-site Fecal Immunochemical Test (FIT) Kit Distribution (Other), Onsite with social media advertising Fecal Immunochemical Test (FIT) Kit… to On-site Fecal Immunochemical Test (FIT) Kit Distribution (Other), On-site With Social Media Advertising Fecal Immunochemical Test (FIT) Kit…
    • Eligibility criteria shortened, about 11 words
    • Secondary endpoints revised (2)
    • Study description shortened, about 105 words
    • Study title expanded, about 6 words

    See this version in full on ClinicalTrials.gov ↗

  5. Primary endpoint revised Interventions: Mailed Fecal Immunochemical Test (FIT) Kit Distribution (Other), On-site Fecal Immunochemical Test (FIT) Kit Distribution (Other) to On-site Fecal Immunochemical Test (FIT) Kit Distribution (Other), Onsite with social media advertising Fecal Immunochemical Test (FIT) Kit… · Secondary endpoints: 1 to 2 · Study description expanded, about 188 wordsv8 Show 3 more changesShow less
    • Interventions: Mailed Fecal Immunochemical Test (FIT) Kit Distribution (Other), On-site Fecal Immunochemical Test (FIT) Kit Distribution (Other) to On-site Fecal Immunochemical Test (FIT) Kit Distribution (Other), Onsite with social media advertising Fecal Immunochemical Test (FIT) Kit…
    • Secondary endpoints: 1 to 2
    • Study description expanded, about 188 words

    See this version in full on ClinicalTrials.gov ↗

Show 6 earlier versionsHide 6 earlier versions
  1. Re-verified, no change to tracked fieldsv7
  2. Primary completion date: Mar 31, 2024 to Mar 2025 Completion date: Jan 31, 2026 to Jan 2026v6 Show 1 more changeShow less
    • Completion date: Jan 31, 2026 to Jan 2026
  3. Trial status: Not Yet Recruiting to Recruiting Primary endpoint revised · Study sites: 0 to 2 · Start date changed from estimate of Oct 1, 2023 to Oct 2, 2023 · 2 morev5 Show 5 more changesShow less
    • Primary endpoint revised
    • Study sites: 0 to 2
    • Start date changed from estimate of Oct 1, 2023 to Oct 2, 2023
    • Interventions: Mailed FIT Distribution (Other), On-site FIT Distribution (Other) to Mailed Fecal Immunochemical Test (FIT) Kit Distribution (Other), On-site Fecal Immunochemical Test (FIT) Kit Distribution (Other)
    • Secondary endpoint revised

    See this version in full on ClinicalTrials.gov ↗

  4. Start date: Sep 1, 2023 to Oct 1, 2023v4
  5. Re-verified, no change to tracked fieldsv3
  6. Study description expanded, about 8 wordsv2 See this version in full on ClinicalTrials.gov ↗
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
African Americans face racial disparities in colorectal cancer (CRC), with lower screening rates and higher incidence and mortality rates. To address this gap and improve CRC screening rates, investigators aims to recruit a total of 1,200 African American participants aged 45-75 during their visits to the DMV, 4606 N 56th St Ste100, Omaha, for CRC screening. All participants will receive a free Fecal Immunochemical Test (FIT) kit with a prepaid return envelope, a culturally tailored educational brochure, reminder text messages and calls, and post-FIT navigation support for participants with positive results or without family doctor/insurance. Kits are returned to a designated Nebraska Medicine lab for testing, and test results will be mailed to participants within 14-21 days. Participants will be assigned to one of two groups: the on-site distribution group or the on-site distribution group with social media advertising group. The social media advertising group will additionally be exposed to targeted ads on platforms like Facebook, Instagram, and YouTube to increase awareness and potentially improve participation rates. The study will compare FIT kit return rates, positive screening rates, and completion rates of follow-up colonoscopies after positive FIT results between the two groups.
Trial Details
NCT Number NCT05903885
Lead Sponsor University of Nebraska
Collaborators: Robert Wood Johnson Foundation
Conditions Colorectal Cancer, Prevention
Enrollment 1,200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov